IL1B and type 1 diabetes mellitus: MIN6 β-cells were exposed to STZ or a T1D-mimicking cytokine mixture (T1D-cytomix: IL-1β, TNF-α, and IFN-γ), with verapamil administered either as pre-treatment, post-treatment, or co-treatment.